1
|
Sarabhai T, Kahl S, Szendroedi J, Markgraf DF, Zaharia OP, Barosa C, Herder C, Wickrath F, Bobrov P, Hwang JH, Jones JG, Roden M. Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance. JCI Insight 2020; 5:134520. [PMID: 32434996 DOI: 10.1172/jci.insight.134520] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 04/09/2020] [Indexed: 01/21/2023] Open
Abstract
BACKGROUNDWhile saturated fat intake leads to insulin resistance and nonalcoholic fatty liver, Mediterranean-like diets enriched in monounsaturated fatty acids (MUFA) may have beneficial effects. This study examined effects of MUFA on tissue-specific insulin sensitivity and energy metabolism.METHODSA randomized placebo-controlled cross-over study enrolled 16 glucose-tolerant volunteers to receive either oil (OIL, ~1.18 g/kg), rich in MUFA, or vehicle (VCL, water) on 2 occasions. Insulin sensitivity was assessed during preclamp and hyperinsulinemic-euglycemic clamp conditions. Ingestion of 2H2O/acetaminophen was combined with [6,6-2H2]glucose infusion and in vivo 13C/31P/1H/ex vivo 2H-magnet resonance spectroscopy to quantify hepatic glucose and energy fluxes.RESULTSOIL increased plasma triglycerides and oleic acid concentrations by 44% and 66% compared with VCL. Upon OIL intervention, preclamp hepatic and whole-body insulin sensitivity markedly decreased by 28% and 27%, respectively, along with 61% higher rates of hepatic gluconeogenesis and 32% lower rates of net glycogenolysis, while hepatic triglyceride and ATP concentrations did not differ from VCL. During insulin stimulation hepatic and whole-body insulin sensitivity were reduced by 21% and 25%, respectively, after OIL ingestion compared with that in controls.CONCLUSIONA single MUFA-load suffices to induce insulin resistance but affects neither hepatic triglycerides nor energy-rich phosphates. These data indicate that amount of ingested fat, rather than its composition, primarily determines the development of acute insulin resistance.TRIAL REGISTRATIONClinicalTrials.gov NCT01736202.FUNDINGGerman Diabetes Center, German Federal Ministry of Health, Ministry of Culture and Science of the state of North Rhine-Westphalia, German Federal Ministry of Education and Research, German Diabetes Association, German Center for Diabetes Research, Portugal Foundation for Science and Technology, European Regional Development Fund, and Rede Nacional de Ressonancia Magnética Nuclear.
Collapse
Affiliation(s)
- Theresia Sarabhai
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - Sabine Kahl
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - Julia Szendroedi
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - Daniel F Markgraf
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - Oana-Patricia Zaharia
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - Cristina Barosa
- Centre for Neurosciences and Cell Biology, UC Biotech, Cantanhede, Portugal.,Portuguese Diabetes Association, Lisbon, Portugal
| | - Christian Herder
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - Frithjof Wickrath
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - Pavel Bobrov
- German Center for Diabetes Research, München-Neuherberg, Germany.,Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| | - Jong-Hee Hwang
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany
| | - John Griffith Jones
- Centre for Neurosciences and Cell Biology, UC Biotech, Cantanhede, Portugal.,Portuguese Diabetes Association, Lisbon, Portugal
| | - Michael Roden
- Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.,German Center for Diabetes Research, München-Neuherberg, Germany.,Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| |
Collapse
|
2
|
Affiliation(s)
- J G Jones
- Representative Forum on Clinical Haemorheology
| |
Collapse
|
3
|
|
4
|
Affiliation(s)
- J G Jones
- Editorial Representative Forum on Clinical Haemorrheology
| |
Collapse
|
5
|
Jones JG. The Hypoxia Hilton: Recollections of a Visit, with a Postscript by JW Severinghaus on Mechanisms of Acute Mountain Sickness. J R Soc Med 2017. [DOI: 10.1177/014107680209501208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- J G Jones
- Woodlands, Rufforth, York YO2 3QF, UK
| |
Collapse
|
6
|
Donovan MJ, Jones JG, Entenberg DR, Condeelis JS, D'alfonso TM, Gustavson M, Molinaro A, Oktay MH, Xue X, Sparano JA, Peterson MA, Podznyakova O, Rohan TE, Shuber AP, Gertler FB, Ly A, Divelbiss ME, Hamilton DA. Abstract P2-05-06: Analytical and clinical validation of a fully automated tissue-based quantitative assay (MetaSite Breast™) to detect the likelihood of distant metastasis in hormone receptor (HR)-positive, HER2-negative early stage breast cancer (ESBC). Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p2-05-06] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: MetaSite Breast™ is a validated assay to predict risk of distant breast cancer metastasis in patients with HR+/HER2- ESBC. The assay measures the number of MetaSites defined as tumor microanatomic structures composed of MENA protein expressing tumor cells in contact with CD31+ endothelial cells and CD68+ macrophages. Previous studies have demonstrated that an increased number of these microanatomic structures is associated with distant metastasis (DM) in HR+/HER2- ESBC independent of clinicopathologic features. Analytical validation of MetaSite Breast™ demonstrated precision of 97-99% (repeat image analysis of the same slide) and performance of 91-96% (staining and image analysis of serial tumor sections). We sought to further understand the importance of the MetaSite in predicting distant breast cancer metastasis utilizing a fully automated prognostic assay in an independent large patient cohort.
Methods: We conducted a nested case-control study within a cohort of 3,760 patients diagnosed between 1980 and 2000 with invasive breast cancer from the Kaiser Permanente Northwest health care system. Cases (n=259) were women who developed a subsequent distant metastasis; controls, selected using incidence density sampling, were matched closely to cases (1:1) on age at and calendar year of primary diagnosis. Of the 481 patient tumor samples evaluated in this study, 57% were HR+/HER2-, 19% were triple negative (TN), and 15% were HER2+ disease. Multivariate models were adjusted for clinical factors including: lymph node status, tumor size, tumor grade, and HRT; as well as matching variables: age and year of diagnosis. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression.
Results: In the HR+/HER2- group, MetaSite Score (MS) ranged from 0-357 and the mean was 44.6. MS was a significant predictor of DM (P=0.039) in patients with HR+/HER2- disease. Cut-points based on tertiles of MS in all 259 controls defined intermediate (13-41) and high (>41) risk groups that were significantly associated with risk of DM versus the low risk group (OR=2.24; 95%CI=1.23-4.13, P=0.009) and (OR=2.94; 95%CI=1.62-5.41, P=0.0005), respectively. Univariate estimates of absolute risk of DM with cutoffs based on 90% sensitivity and specificity were 9.4% for the low risk group (MS<7), 14.1% for the intermediate (MS=7-91), and 23.4% for the high (MS>91). When adjusted for clinical factors, estimates of absolute risk of DM were 6.6%, 14.1%, and 33.0% for the low, intermediate, and high risk groups, respectively. A binary cut-point for the high risk group was determined (MS>14) and was significant with a 2-fold higher risk of DM versus the low risk group and adjusted for clinical covariates (P=0.036). MS was not positively associated with DM in TN or HER2+ disease.
Conclusions: MetaSite Breast™ significantly predicted the risk of distant breast cancer metastasis in ESBC patients with HR+/HER2-disease, independent of classical clinicopathologic features.
Citation Format: Donovan MJ, Jones JG, Entenberg DR, Condeelis JS, D'alfonso TM, Gustavson M, Molinaro A, Oktay MH, Xue X, Sparano JA, Peterson MA, Podznyakova O, Rohan TE, Shuber AP, Gertler FB, Ly A, Divelbiss ME, Hamilton DA. Analytical and clinical validation of a fully automated tissue-based quantitative assay (MetaSite Breast™) to detect the likelihood of distant metastasis in hormone receptor (HR)-positive, HER2-negative early stage breast cancer (ESBC) [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-06.
Collapse
Affiliation(s)
- MJ Donovan
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - JG Jones
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - DR Entenberg
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - JS Condeelis
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - TM D'alfonso
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - M Gustavson
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - A Molinaro
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - MH Oktay
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - X Xue
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - JA Sparano
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - MA Peterson
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - O Podznyakova
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - TE Rohan
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - AP Shuber
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - FB Gertler
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - A Ly
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - ME Divelbiss
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| | - DA Hamilton
- Icahn School of Medicine at Mount Sinai, New York, NY; Albert Einstein College of Medicine, New York, NY; Montefiore, New York, NY; MetaStat, Inc., Boston, MA; Massachusetts General Hospital/Harvard Medical School, Boston, MA; Brigham and Womens Hospital/Harvard Medical School, Boston, MA; University of California, San Francisco, San Francisco, CA; Weill Cornell Medicine, New York, NY; Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA; Alberta Health Services, Calgary, AB, Canada
| |
Collapse
|
7
|
Karagiannis GS, Pastoriza JM, Wang Y, Harney AS, Entenberg D, Pignatelli J, Jones JG, Anampa J, Sparano JA, Rohan TE, Condeelis JS, Oktay MH. Abstract PD5-02: Paclitaxel induced mena- and TMEM-mediated pro-metastatic changes in the breast cancer microenvironment. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-pd5-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Breast cancer cell intravasation and dissemination occurs specifically at microanatomical structures that we call tumor-microenvironment of metastasis (TMEM), representing direct physical contact between a tumor cell expressing the actin-regulatory protein Mammalian-enabled (Mena), a perivascular Tie2hi/Vegfhi-expressing macrophage, and an endothelial cell (Harney et al. Cancer Discovery 2015). TMEM sites have been identified in mouse and human mammary carcinomas, and both TMEM density (Rohan et al. JNCI 2014) and invasive Mena isoform expression (Agarwal et al. Breast Cancer Res, 2012; Forse et al. BMC Cancer, 2015]) correlates with metastasis in early stage breast cancer. Since cytotoxic agents such as PTX induce influx of bone marrow-derived progenitors that differentiate into Tie2hi/VEGFhi macrophages in the primary tumor, we hypothesized that PTX may potentiate tumor cell invasion and metastasis by inducing the formation of TMEM sites and/or function.
Methods and Results in humans: We analyzed the effect of chemotherapy on TMEM and invasive Mena isoforms in 10 patients with localized breast cancer who had residual disease after neoadjuvant chemotherapy (NAC: weekly paclitaxel followed by dose-dense doxorubicin-cyclophosphamide [AC]), of whom 7 had more than 2-fold increase in TMEM density in residual disease compared with pretreatment. In a separate cohort of 5 patients, NAC produced an acute increase of up to 150-fold in invasive Mena isoforms after 1-2 doses of NAC.
Methods and Results in mice: After our preliminary data in humans, we evaluated effects of PTX in 4 different models, including 2 mouse models (PyMT-spontaneous & transplantation) and 2 patient-derived xenograft (PDX) triple negative models (HT17, HT33). Although PTX delayed primary tumor growth, tumors in PTX-treated mice had significantly more TMEM sites, circulating tumor cells (CTCs) and metastatic foci when compared to vehicle-treated animals. Using intravital imaging of MMTV-PyMT-Dendra2/Cfms-CFP mice, PTX induced influx of macrophages into primary tumors and intravasation of cancer cells at TMEM sites. Furthermore, PTX treatment significantly increased expression of Mena at the gene and protein levels, including invasive Mena isoforms. Deletion of the Mena gene completely abolished dissemination and metastasis in all cases, including those treated with PTX.
Conclusions: We show in mammary carcinoma mouse models and PDX models that although PTX delays tumor growth, it induces invasive Mena isoform expression and significantly increases the density of TMEM sites that are responsible for cancer cell intravasation, dissemination and metastasis. Thus, our data indicate that PTX paradoxically induces dissemination of breast cancer cells by promoting invasive Mena isoforms and TMEM-mediated cancer cell intravasation, suggesting that blockade of TMEM assembly and/or function could enhance the effectiveness of PTX and possibly other cytotoxic agents commonly used to treat early and advanced stage breast cancer.
Citation Format: Karagiannis GS, Pastoriza JM, Wang Y, Harney AS, Entenberg D, Pignatelli J, Jones JG, Anampa J, Sparano JA, Rohan TE, Condeelis JS, Oktay MH. Paclitaxel induced mena- and TMEM-mediated pro-metastatic changes in the breast cancer microenvironment [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr PD5-02.
Collapse
Affiliation(s)
- GS Karagiannis
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - JM Pastoriza
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - Y Wang
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - AS Harney
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - D Entenberg
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - J Pignatelli
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - JG Jones
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - J Anampa
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - JA Sparano
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - TE Rohan
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - JS Condeelis
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| | - MH Oktay
- Albert Einstein College of Medicine, Bronx, NY; Montefiore Medical Center, Bronx, NY
| |
Collapse
|
8
|
Flachs P, Adamcova K, Zouhar P, Marques C, Janovska P, Viegas I, Jones JG, Bardova K, Svobodova M, Hansikova J, Kuda O, Rossmeisl M, Liisberg U, Borkowska AG, Kristiansen K, Madsen L, Kopecky J. Induction of lipogenesis in white fat during cold exposure in mice: link to lean phenotype. Int J Obes (Lond) 2016; 41:372-380. [PMID: 28008171 DOI: 10.1038/ijo.2016.228] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/22/2016] [Revised: 11/10/2016] [Accepted: 11/24/2016] [Indexed: 12/12/2022]
Abstract
BACKGROUND/OBJECTIVE Futile substrate cycling based on lipolytic release of fatty acids (FA) from intracellular triacylglycerols (TAG) and their re-esterification (TAG/FA cycling), as well as de novo FA synthesis (de novo lipogenesis (DNL)), represent the core energy-consuming biochemical activities of white adipose tissue (WAT). We aimed to characterize their roles in cold-induced thermogenesis and energy homeostasis. METHODS Male obesity-resistant A/J and obesity-prone C57BL/6J mice maintained at 30 °C were exposed to 6 °C for 2 or 7 days. In epididymal WAT (eWAT), TAG synthesis and DNL were determined using in vivo 2H incorporation from 2H2O into tissue TAG and nuclear magnetic resonance spectroscopy. Quantitative real-time-PCR and/or immunohistochemistry and western blotting were used to determine the expression of selected genes and proteins in WAT and liver. RESULTS The mass of WAT depots declined during cold exposure (CE). Plasma levels of TAG and non-esterified FA were decreased by day 2 but tended to normalize by day 7 of CE. TAG synthesis (reflecting TAG/FA cycle activity) gradually increased during CE. DNL decreased by day 2 of CE but increased several fold over the control values by day 7. Expression of genes involved in lipolysis, glyceroneogenesis, FA re-esterification, FA oxidation and mitochondrial biogenesis in eWAT was induced during CE. All these changes were more pronounced in obesity-resistant A/J than in B6 mice and occurred in the absence of uncoupling protein 1 in eWAT. Expression of markers of glyceroneogenesis in eWAT correlated negatively with hepatic FA synthesis by day 7 in both strains. Leptin and fibroblast growth factor 21 plasma levels were differentially affected by CE in the two mouse strains. CONCLUSIONS Our results indicate integrated involvement of (i) TAG/FA cycling and DNL in WAT, and (ii) hepatic very-low-density lipoprotein-TAG synthesis in the control of blood lipid levels and provision of FA fuels for thermogenesis in cold. They suggest that lipogenesis in WAT contributes to a lean phenotype.
Collapse
Affiliation(s)
- P Flachs
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - K Adamcova
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - P Zouhar
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - C Marques
- Centre for Neuroscience and Cell Biology, University of Coimbra, Cantanhede, Portugal
| | - P Janovska
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - I Viegas
- Centre for Neuroscience and Cell Biology, University of Coimbra, Cantanhede, Portugal
| | - J G Jones
- Centre for Neuroscience and Cell Biology, University of Coimbra, Cantanhede, Portugal
| | - K Bardova
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - M Svobodova
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - J Hansikova
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - O Kuda
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - M Rossmeisl
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| | - U Liisberg
- Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark.,National Institute of Nutrition and Seafood Research, Bergen, Norway
| | - A G Borkowska
- Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark
| | - K Kristiansen
- Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark.,BGI-Shenzhen, Shenzhen, China
| | - L Madsen
- Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark.,National Institute of Nutrition and Seafood Research, Bergen, Norway
| | - J Kopecky
- Department of Adipose Tissue Biology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
| |
Collapse
|
9
|
Jones JG, White KAJ, Delgado-Charro MB. A mechanistic approach to modelling the formation of a drug reservoir in the skin. Math Biosci 2016; 281:36-45. [PMID: 27592115 DOI: 10.1016/j.mbs.2016.08.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2016] [Revised: 06/12/2016] [Accepted: 08/24/2016] [Indexed: 11/26/2022]
Abstract
It has been shown that prolonged systemic presence of a drug can cause a build-up of that drug in the skin. This drug 'reservoir', if properly understood, could provide useful information about recent drug-taking history of the patient. We create a pair of coupled mathematical models which combine to explore the potential for a drug reservoir to establish based on the kinetic properties of the drug. The first compartmental model is used to characterise time-dependent drug concentrations in plasma and tissue following a customisable drug regimen. Outputs from this model provide boundary conditions for the second, spatio-temporal model of drug build-up in the skin. We focus on drugs that are highly bound as this will restrict their potential to move freely into the skin but which are lipophilic so that, in the unbound form, they would demonstrate an affinity to the outer layers of the skin. Buprenorphine, a drug used to treat opiate addiction, is one example of a drug satisfying these properties. In the discussion we highlight how our study might be used to inform future experimental design and data collection to provide relevant parameter estimates for reservoir formation and its potential to contribute to enhanced drug monitoring techniques.
Collapse
Affiliation(s)
- J G Jones
- Department of Mathematical Sciences, University of Bath, Bath BA2 7AY, UK; Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK.
| | - K A J White
- Department of Mathematical Sciences, University of Bath, Bath BA2 7AY, UK.
| | - M B Delgado-Charro
- Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK.
| |
Collapse
|
10
|
Affiliation(s)
- J G Jones
- Guy's Arthritis Research Unit, Guy's Hospital Medical School, London SE1 9RT
| |
Collapse
|
11
|
Jones JG, Lockwood GG, Fung N, Lasenby J, Ross-Russell RI, Quine D, Stenson BJ. Influence of pulmonary factors on pulse oximeter saturation in preterm infants. Arch Dis Child Fetal Neonatal Ed 2016; 101:F319-22. [PMID: 26602315 DOI: 10.1136/archdischild-2015-308675] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2015] [Accepted: 10/08/2015] [Indexed: 11/04/2022]
Abstract
AIM To describe how the stability of oxygen saturation measured by pulse oximetry (SpO2%) varies within and between infants with bronchopulmonary dysplasia (BPD). METHODS Clinically stable infants with BPD had SpO2 measured at different inspired oxygen concentrations (FIO2 expressed as %). A computer model of gas exchange, that is, ventilation/perfusion ratio (VA/Q) and shunt, plotted the curve of SpO2 versus FIO2 best fitting these data. The slope of this curve is the change in SpO2 per % change in FIO2, hence SpO2 stability, calculated at each SpO2 from 85% to 95%. RESULTS Data from 16 infants with BPD previously described were analysed. The dominant gas exchange impairment was low VA/Q (median 0.35, IQR, 0.16-0.4, normal 0.86). Median shunt was 1% (IQR, 0-10.5; normal <2%). Slope varied markedly between infants, but above 95% SpO2 was always <1.5. In infants with least severe BPD (VA/Q ≈0.4, shunt ≤2%) median slope at 85% SpO2 was 5.1 (IQR, 3.7-5.5). With more severe BPD (VA/Q ≤0.3) slope was flatter throughout the SpO2 range. The highest FIO2 for 90% SpO2 was in infants with the lowest VA/Q values. CONCLUSIONS In infants with BPD, there was large variation in the slope of the curve relating SpO2% to inspired oxygen fraction in the SpO2 range 85%-95%. Slopes were considerably steeper at lower than higher SpO2, especially in infants with least severe BPD, meaning that higher SpO2 target values are intrinsically much more stable. Steep slopes below 90% SpO2 may explain why some infants appear dependent on remarkably low oxygen flows.
Collapse
Affiliation(s)
- J G Jones
- Department of Anaesthesia, Addenbrookes Hospital, Cambridge, UK
| | - G G Lockwood
- Anaesthetic Department, Hammersmith Hospital, London, UK
| | - N Fung
- Signal Processing Group, Cambridge University Engineering Department, Cambridge, UK Biomedical Signals and Systems Group, Faculty of Electrical Engineering, Mathematics and Computer Science, University of Twente, Enschede, The Netherlands
| | - J Lasenby
- Signal Processing Group, Cambridge University Engineering Department, Cambridge, UK
| | | | - D Quine
- Neonatal Unit, Royal Infirmary of Edinburgh, Edinburgh, UK
| | - B J Stenson
- Neonatal Unit, Royal Infirmary of Edinburgh, Edinburgh, UK
| |
Collapse
|
12
|
Ginter PS, Robinson BD, D'Alfonso TM, Oktay MH, Gertler FB, Rohan TE, Condeelis JS, Jones JG. Abstract P6-02-04: TMEM (Tumor MicroEnvironment of Metastasis) in human breast cancer is a blood vessel associated intravasation microenvironment unrelated to lymphatics. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p6-02-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
In breast cancer, both lymph node and distant metastasis represent dissemination of tumor cells from a primary site, but the mechanism of spread and the subsequent risk of mortality may not be the same. Historically, lymphatic spread has been documented both descriptively, as presence or absence of lymphovascular invasion (LVI), and as a formal part of TNM staging. Until recently, however, there has been no way to directly assess the risk of hematogenous dissemination by the primary tumor.
Observations from multiphoton-based intravital imaging of rodent models of breast cancer and the analysis of Mena function in tumor cells in vivo have characterized an intravasation microenvironment (ME) involved in the systemic dissemination of tumor cells from primary breast tumors. We have identified the corresponding structure in FFPE tissue and called it TMEM (Tumor MicroEnvironment of Metastasis). This microanatomic landmark is defined as the direct apposition of a Mena-overexpressing intravasation competent carcinoma cell, a perivascular macrophage, and an endothelial cell. In a case control study of 30 case-control pairs, where each matched pair differed only in their metastatic status – non-metastatic vs. metastatic – we found that the density of TMEM was significantly associated with development of systemic metastasis (p = 0.00006).
The relationship of hematogenous- and lymphatic-mediated tumor cell spread is not understood. Using the previously described cohort in which we showed that TMEM was associated with metastasis, the purpose of this study was to 1) assess intratumoral lymphatic density, 2) determine if TMEM- lymphatic structures associated with lymphatics exist, and 3) determine if TMEM- lymphatic structures correlate with systemic metastatic risk. Cases were stained with a triple immunostain identical to that used in our earlier study except that D2-40 (a lymphatic marker) was used, rather than CD31 (a blood vessel marker). The marker for macrophages (CD68) and invasive tumor cells (Mena) remained the same. Two pathologists, blinded to outcome, evaluated the presence or absence of intratumoral lymphatics and quantitated the number of TMEM-lymphatic structures per 10 high power (400x) fields in areas of highest intratumoral lymphatic density. A TMEM-lymphatic structure was defined as the direct apposition of a lymphatic (D2-40) endothelial cell with a macrophage and invasive tumor cell.
Intratumoral lymphatics were absent in a majority of tumors in each of the 2 groups (18 of 30 non-metastatic, 16 of 30 metastatic; p = 0.6). TMEM-lymphatic structures were rare and were equally present in the 2 groups (3 metastatic and 3 non-metastatic cases). Using the Wilcoxon (paired) signed-rank test, we found no significant difference in the density of these structures between the two groups (p = 0.4). Furthermore, TMEM-lymphatic structures did not correlate with the presence of lymph node metastases (p = 0.8). We conclude that lymphatic vessels do not participate in the TMEM assembly that has been associated with hematogenous metastasis. TMEM density assessment reflects a hematogenous intravasation ME and offers a novel approach to the assessment of metastatic risk.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P6-02-04.
Collapse
Affiliation(s)
- PS Ginter
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| | - BD Robinson
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| | - TM D'Alfonso
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| | - MH Oktay
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| | - FB Gertler
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| | - TE Rohan
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| | - JS Condeelis
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| | - JG Jones
- Weill Cornell Medical College, New York, NY; Albert Einstein College of Medicine, Bronx, NY; Massachusetts Institute of Technology, Cambridge, MA
| |
Collapse
|
13
|
Schreiner AM, Jones JG, Swistel AJ, Hoda RS. Transthoracic fine needle aspiration resulting in implantation metastasis in the superficial tissues of the breast. Cytopathology 2012; 24:58-60. [PMID: 22548446 DOI: 10.1111/j.1365-2303.2012.00977.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- A M Schreiner
- Department of Pathology, New York Presbyterian Hospital, Weill Cornell Medical College, NY, USA.
| | | | | | | |
Collapse
|
14
|
Kacerovsky M, Brehm A, Chmelik M, Schmid AI, Szendroedi J, Kacerovsky-Bielesz G, Nowotny P, Lettner A, Wolzt M, Jones JG, Roden M. Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes. J Intern Med 2011; 269:189-99. [PMID: 21205021 DOI: 10.1111/j.1365-2796.2010.02298.x] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
OBJECTIVE in type 2 diabetic patients and their first-degree relatives, insulin resistance (IR) is associated with impairment of insulin-stimulated myocellular glucose-6-phosphate (g6p) and unidirectional flux through ATP synthase (fATP), suggesting the presence of inherited abnormal mitochondrial oxidative fitness. We hypothesized that patients with long-standing type 1 diabetes may also exhibit insulin resistance as well as lower fATP. DESIGN this single-centre trial was registered at ClinicalTrials.gov (NCT00481598). SUBJECTS we included eight nonobese type 1 diabetic patients (mean diabetes duration: 17 years) with near-target glycaemic control [haemoglobin A1c (HbA1c): 6.8 ± 0.4%] during treatment with continuous subcutaneous insulin infusion pumps and eight healthy volunteers (HbA1c: 5.4 ± 0.2%) of comparable age, body mass and level of physical activity. OUTCOME MEASURES myocellular fATP, g6p and intramyocellular lipid content (IMCL) were measured with (1) H/(31) P magnetic resonance spectroscopy during fasting and hyperinsulinaemic-euglycaemic clamp tests. RESULTS fasting fATP, g6p and IMCL did not differ between groups. During stimulation by insulin, type 1 diabetic patients exhibited approximately 50% (P < 0.001) lower whole-body glucose disposal along with approximately 42% (P = 0.003) lower intramyocellular g6p and approximately25% (P = 0.024) lower fATP. Insulin-stimulated fATP correlated positively with whole-body insulin sensitivity (R = 0.706, P = 0.002) and negatively with HbA1c (R = -0.675, P = 0.004). CONCLUSIONS despite documented near-target glycaemic control for 1 year, nonobese patients with long-standing type 1 diabetes can exhibit insulin resistance. This associates with lower insulin-stimulated flux through muscular ATP synthase which could result from glucose toxicity.
Collapse
Affiliation(s)
- M Kacerovsky
- Karl-Landsteiner Institute for Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Agarwal S, Jones JG, Oktay M, Balsamo M, Condeelis J, Gertler F, Rimm DL. Abstract P3-10-16: Quantitative Subtractive Immunofluorescence To Develop a Surrogate for Mena Inv(asive) Isoform Is Associated with Poor Outcome in Breast Cancer. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p3-10-16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction:
Previous work has shown that the inv isoform of Mena, an actin binding protein, is associated with invasion at the cellular level and metastasis in the context of the microenvironment in both animal models and humans (Robinson, B.D. et al. Clin Cancer Res 15, 2433-2441 (2009). However, the prognostic value for metastasis of MenaINV itself is unknown because there is no antibody that directly recognizes this isoform. Here we describe a method to assess a surrogate for MenaINV by measuring total Mena and subtracting the levels of the 11a (non-invasive) isoform. Method: Total Mena and Mena11a were measured in two independent retrospective breast cancer cohorts with 20 year follow-up using tissue microarray and quantitative immunofluorescence (AQUA) technology in a previously described multiplexed mode. AQUA scores for each marker were converted into z scores followed by subtraction of Mena 11a (noninvasive form of Mena) from total Mena (invasive and non-invasive) = Mena(inv) surrogate. This was calculated for each patient and correlated with clinical and pathological characteristics as well as disease-free survival in both cohorts.
Results: In the older Yale cohort, Kaplan Meier analysis dividing the Mena(inv) surrogate by quartiles suggested collapse of the top three quartiles followed by comparison to the fourth quartile (log rank p= 0.0003, n=501). The 4th quartile was also significant in node positive (log rank p=0.0047, n=267) and estrogen negative (ER) patient subgroups (log rank p=0.0003, n=234). Cox multivariate analysis showed Mena(inv) was independent of age, tumor size, nuclear grade, nodal status, ER, PR, Her2 (HR=0.636, 95% CI=0.47-0.86, p=0.0038, n=420). The newer Yale cohort showed similar results, but that cohort also had data on local vs. distant recurrence. The relative risk of distant recurrence in this cohort is 2.56 (p=0.011) for patients with high Mena (inv) compared to 1.96 (p=0.055) for any recurrence.
Conclusions: High Mena (inv) surrogate shows prognostic value for poor survival in two independent breast cancer cohorts with some suggestion of preferential prognostic value for distant recurrence.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P3-10-16.
Collapse
Affiliation(s)
- S Agarwal
- Yale University School of Medicine, New Haven, CT; Weill Cornell University, New York, NY; Montefiore Medical Center, Bronx, NY; Koch Institute, MIT, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY
| | - JG Jones
- Yale University School of Medicine, New Haven, CT; Weill Cornell University, New York, NY; Montefiore Medical Center, Bronx, NY; Koch Institute, MIT, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY
| | - M Oktay
- Yale University School of Medicine, New Haven, CT; Weill Cornell University, New York, NY; Montefiore Medical Center, Bronx, NY; Koch Institute, MIT, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY
| | - M Balsamo
- Yale University School of Medicine, New Haven, CT; Weill Cornell University, New York, NY; Montefiore Medical Center, Bronx, NY; Koch Institute, MIT, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY
| | - J Condeelis
- Yale University School of Medicine, New Haven, CT; Weill Cornell University, New York, NY; Montefiore Medical Center, Bronx, NY; Koch Institute, MIT, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY
| | - F Gertler
- Yale University School of Medicine, New Haven, CT; Weill Cornell University, New York, NY; Montefiore Medical Center, Bronx, NY; Koch Institute, MIT, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY
| | - DL Rimm
- Yale University School of Medicine, New Haven, CT; Weill Cornell University, New York, NY; Montefiore Medical Center, Bronx, NY; Koch Institute, MIT, Cambridge, MA; Albert Einstein College of Medicine, Bronx, NY
| |
Collapse
|
16
|
Abstract
Studies of food remains from the Preceramic monumental site of E1 Paraíso, Peru (1800 to 1500 B.C.), have shed new light on a debate regarding the relative importance of seafood versus terrestrial resources and the role of cultigens in subsistence economies during the early development of Peruvian civilization. Fish was the primary animal food at the site whereas plant foods consisted of a mixture of cultivated resources (squashes, beans, peppers, and jicama) with an additional reliance on fruits (guava, lucuma, and pacae). Wild plants, especially the roots of sedges and cat-tail, also may have accounted for a substantial part of the diet. Cotton was a chief crop, used in making fishing tackle and the textiles that served as clothing and items of high value and status. As an example of the beginnings of civilization, El Paraíso is a case in which impressive architecture was built on a relatively simple subsistence economy and energy was expended in the production of resources useful in local and regional exchange systems.
Collapse
|
17
|
Dassarma S, Halladay JT, Jones JG, Donovan JW, Giannasca PJ, de Marsac NT. High-frequency mutations in a plasmid-encoded gas vesicle gene in Halobacterium halobium. Proc Natl Acad Sci U S A 2010; 85:6861-5. [PMID: 16593983 PMCID: PMC282078 DOI: 10.1073/pnas.85.18.6861] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Gas vesicle-deficient mutants of Halobacterium halobium arise spontaneously at high frequency (about 1%). The mutants are readily detected, forming translucent colonies on agar plates in contrast to opaque wild-type colonies. To investigate the mechanism of this mutation, we recently cloned a plasmid-encoded gas vesicle protein gene, gvpA, from H. halobium. In the wild-type NRC-1 strain the gvpA gene is encoded by a multicopy plasmid of approximately 150 kilobase pairs (kb). We have now characterized 18 gas vesicle-deficient mutants and 4 revertants by phenotypic and Southern hybridization analyses. Our results indicate that the mutants fall into three major classes. Class I mutants are partially gas vesicle-deficient (Vac(delta-)) and unstable, giving rise to completely gas vesicle-deficient (Vac(-)) derivatives and Vac(+) revertants at frequencies of 1-5%. The restriction map of the gvpA gene region in class I mutants is unchanged but the gene copy number is reduced compared to the Vac(+) strains. Class II mutants can be either Vac(delta-) or completely Vac(-) but are relatively stable. They contain insertion sequences within or upstream of the gvpA gene. A Vac(-) class II mutant, R1, contains the 1.3-kb insertion sequence, ISH3, within the gvpA gene, whereas four Vac(delta-) class II mutants contain other insertion sequences upstream of the gene. Class III mutants are stable Vac(-) derivatives of either the wild-type or class I mutants and have no detectable copies of the gvpA gene. Based on these results, we discuss the mechanisms of gas vesicle mutations in H. halobium.
Collapse
Affiliation(s)
- S Dassarma
- Department of Microbiology, University of Massachusetts, Amherst, MA 01003
| | | | | | | | | | | |
Collapse
|
18
|
Gray ND, Pickup RW, Jones JG, Head IM. Ecophysiological Evidence that Achromatium oxaliferum Is Responsible for the Oxidation of Reduced Sulfur Species to Sulfate in a Freshwater Sediment. Appl Environ Microbiol 2010; 63:1905-10. [PMID: 16535604 PMCID: PMC1389159 DOI: 10.1128/aem.63.5.1905-1910.1997] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Achromatium oxaliferum is a large, morphologically conspicuous, sediment-dwelling bacterium. The organism has yet to be cultured in the laboratory, and very little is known about its physiology. The presence of intracellular inclusions of calcite and sulfur have given rise to speculation that the bacterium is involved in the carbon and sulfur cycles in the sediments where it is found. Depth profiles of oxygen concentration and A. oxaliferum cell numbers in a freshwater sediment revealed that the A. oxaliferum population spanned the oxic-anoxic boundary in the top 3 to 4 cm of sediments. Some of the A. oxaliferum cells resided at depths where no oxygen was detectable, suggesting that these cells may be capable of anaerobic metabolism. The distributions of solid-phase and dissolved inorganic sulfur species in the sediment revealed that A. oxaliferum was most abundant where sulfur cycling was most intense. The sediment was characterized by low concentrations of free sulfide. However, a comparison of sulfate reduction rates in sediment cores incubated with either oxic or anoxic overlying water indicated that the oxidative and reductive components of the sulfur cycle were tightly coupled in the A. oxaliferum-bearing sediment. A positive correlation between pore water sulfate concentration and A. oxaliferum numbers was observed in field data collected over an 18-month period, suggesting a possible link between A. oxaliferum numbers and the oxidation of reduced sulfur species to sulfate. The field data were supported by laboratory incubation experiments in which sodium molybdate-treated sediment cores were augmented with highly purified suspensions of A. oxaliferum cells. Under oxic conditions, rates of sulfate production in the presence of sodium molybdate were found to correlate strongly with the number of cells added to sediment cores, providing further evidence for a role for A. oxaliferum in the oxidation of reduced sulfur.
Collapse
|
19
|
Abstract
BACKGROUND Right to left shunt and regional hypoventilation (reduced ventilation/perfusion ratio (V(A)/Q)) have different effects on the curve relating inspired oxygen (P(I)O(2)) to oxygen saturation measured by pulse oximetry (SpO(2)) and can be derived non-invasively from measurements of SpO(2) and inspired oxygen pressure (P(I)O(2)) using complex models of gas exchange. We developed a simpler computerised "slide-rule" method of making these derivations. AIMS To describe the slide-rule method and determine agreement between measurements derived with this and a more complex algorithm. METHODS Series of P(I)O(2) versus SpO(2) data points obtained during 43 studies in 16 preterm infants with bronchopulmonary dysplasia were analysed. Percentage shunt and the degree of right shift (kPa) of the P(I)O(2) versus SpO(2) curve compared with the oxyhaemoglobin dissociation curve (a measure of V(A)/Q) were determined for each dataset with both methods, and the results were compared using the method of Bland and Altman. RESULTS The computer slide-rule method produced results for all 43 datasets. The more complex model could derive results for 40/43 datasets. The mean differences (95% limits of agreement) between the two methods for measurements of shunt were -1.7% (-6.5 to +3.5%) and for measurements of right shift were 0.3 kPa (-2.9 to +3.6 kPa). CONCLUSION The slide-rule method was reliable for deriving shunt and right shift (reduced V(A)/Q) of the P(I)O(2) versus SpO(2) curve when compared with the more complex algorithm. The new method should enable wider clinical application of these measurements of oxygen exchange.
Collapse
Affiliation(s)
- L Rowe
- Department of Anaesthetics, Norfolk and Norwich University Hospital, Norwich, UK
| | | | | | | | | |
Collapse
|
20
|
Delgado TC, Pinheiro D, Caldeira M, Castro MMCA, Geraldes CFGC, López-Larrubia P, Cerdán S, Jones JG. Sources of hepatic triglyceride accumulation during high-fat feeding in the healthy rat. NMR Biomed 2009; 22:310-317. [PMID: 19012281 DOI: 10.1002/nbm.1327] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Hepatic triglyceride (HTG) accumulation from peripheral dietary sources and from endogenous de novo lipogenesis (DNL) was quantified in adult Sprague-Dawley rats by combining in vivo localized (1)H MRS measurement of total hepatic lipid with a novel ex vivo (2)H NMR analysis of HTG (2)H enrichment from (2)H-enriched body water. The methodology for DNL determination needs further validation against standard methodologies. To examine the effect of a high-fat diet on HTG concentrations and sources, animals (n = 5) were given high-fat chow for 35 days. HTG accumulation, measured by in vivo (1)H MRS, increased significantly after 1 week (3.85 +/- 0.60% vs 2.13 +/- 0.34% for animals fed on a standard chow diet, P < 0.05) and was maintained until week 5 (3.30 +/- 0.60% vs 1.12 +/- 0.30%, P < 0.05). Animals fed on a high-fat diet were glucose intolerant (13.3 +/- 1.3 vs 9.4 +/- 0.8 mM in animals fed on a standard chow diet, for 60 min glycemia after glucose challenge, P < 0.05). In control animals, DNL accounted for 10.9 +/- 1.0% of HTG, whereas in animals given the high-fat diet, the DNL contribution was significantly reduced to 1.0 +/- 0.2% (P < 0.01 relative to controls). In a separate study to determine the response of HTG to weaning from a high-fat diet, animals with raised HTG (3.33 +/- 0.51%) after 7 days of a high-fat diet reverted to basal HTG concentrations (0.76 +/- 0.06%) after an additional 7 days of weaning on a standard chow diet. These studies show that, in healthy rats, HTG concentrations are acutely influenced by dietary lipid concentrations. Although the DNL contribution to HTG content is suppressed by a high-fat diet in adult Sprague-Dawley rats, this effect is insufficient to prevent overall increases in HTG concentrations.
Collapse
Affiliation(s)
- T C Delgado
- Biochemistry Department, Coimbra University, Coimbra, Portugal
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Alves TC, Nunes PM, Palmeira CM, Jones JG, Carvalho RA. Estimating gluconeogenesis by NMR isotopomer distribution analysis of [13C]bicarbonate and [1-13C]lactate. NMR Biomed 2008; 21:337-44. [PMID: 17683055 DOI: 10.1002/nbm.1195] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
The gluconeogenic contribution to glucose production in livers isolated from rats fasted for 24 h was determined by 13C-NMR isotopomer distribution analysis of secreted glucose enriched from 99% [13C]bicarbonate (n = 4) and 99% [1-13C]lactate (n = 4). Experiments with 3% 2H2O were also performed, allowing the gluconeogenic contribution to be measured by the relative 2H enrichments at positions 5 and 2 of glucose. From 13C-NMR analyses, the contribution of gluconeogenesis to glucose output was estimated to be 93 +/- 3% for [13C]bicarbonate perfusion and 91 +/- 3% for [1-13C]lactate perfusion, in good agreement with the 2H-NMR analysis of the gluconeogenic contribution to glucose production (100 +/- 1% and 99 +/- 1%, respectively) and consistent with the expected negligible contribution from glycogenolysis. These results indicate that 13C-NMR analysis of glucose 13C-isotopomer distribution from either [13C]bicarbonate or [1-13C]lactate precursor provides realistic estimates of the gluconeogenic contribution to hepatic glucose output.
Collapse
Affiliation(s)
- Tiago Cardoso Alves
- Department of Biochemistry, Faculty of Sciences and Technology, University of Coimbra, Coimbra, Portugal
| | | | | | | | | |
Collapse
|
22
|
Sena CM, Barosa C, Nunes E, Seiça R, Jones JG. Sources of endogenous glucose production in the Goto–Kakizaki diabetic rat. Diabetes & Metabolism 2007; 33:296-302. [PMID: 17553720 DOI: 10.1016/j.diabet.2007.03.002] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/05/2006] [Accepted: 03/18/2007] [Indexed: 10/23/2022]
Abstract
Plasma glucose, insulin and glucose tolerance were quantified in diabetic Goto-Kakizaki (GK) rats (342+/-45 g, n = 5) and compared with weight-matched non-diabetic Wistars (307+/-30 g, n = 8). Compared to Wistars, GK rats had higher fasting plasma insulin (219+/-50 versus 44+/-14 pmol/l, P<0.002) and glucose (9.2+/-2.3 versus 5.5+/-0.5 mmol/l, P<0.025). GK rats showed impaired glucose tolerance (IPGTT 2 h plasma glucose=14+/-1.5 versus 6.4+/-0.1 mmol/l, P<0.001). Endogenous glucose production (EGP) from glycogenolysis, phosphoenolpyruvate (PEP) and glycerol after 6 hours of fasting was quantified by a primed infusion of [U-(13)C]glucose and (2)H(2)O tracers and (2)H/(13)C NMR analysis of plasma glucose. EGP was higher in GK compared to Wistar rats (191+/-16 versus 104+/-27 mumol/kg per min, P<0.005). This was sustained by increased gluconeogenesis from PEP (85+/-12 versus 35+/-4 mumol/kg per min, P<0.02). Gluconeogenesis from glycerol was not different (20+/-3 in Wistar versus 30+/-6 mumol/kg per min for GK), and glycogenolysis fluxes were also not significantly different (76+/-23 mumol/kg per min for GK versus 52+/-19 mumol/kg per min for Wistar). The Cori cycle accounted for most of PEP gluconeogenesis in both Wistar and GK rats (85+/-15% and 77+/-10%, respectively). Therefore, increased gluconeogenesis in GK rats is largely sustained by increased Cori cycling while the maintenance of glycogenolysis indicates a failure in hepatic autoregulation of EGP.
Collapse
Affiliation(s)
- C M Sena
- Institute of Physiology, Faculty of Medicine, University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal.
| | | | | | | | | |
Collapse
|
23
|
Jones JG. The rehabilitation model rules in RA until biomedicine transforms tomorrow's rheumatologist into a real thaumaturgus. Rheumatology (Oxford) 2007; 46:890-1; author reply 891-2. [PMID: 17329354 DOI: 10.1093/rheumatology/kel438] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
24
|
|
25
|
Jones JG. Ankle Brachial Pressure Index. J R Soc Med 2007. [DOI: 10.1258/jrsm.100.3.117-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
26
|
Brozanski BS, Jones JG, Krohn MJ, Jordan JA. Use of polymerase chain reaction as a diagnostic tool for neonatal sepsis can result in a decrease in use of antibiotics and total neonatal intensive care unit length of stay. J Perinatol 2006; 26:688-92. [PMID: 17024143 DOI: 10.1038/sj.jp.7211597] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE To retrospectively determine if a negative 16S ribosomal RNA (rRNA) polymerase chain reaction (PCR) (PCR(-)) could lead to a decrease in the number of antibiotic doses and neonatal intensive care unit (NICU) length of stay (LOS) for infants admitted to the NICU for presumed early-onset sepsis (EOS) with negative blood culture results (BC(-)). STUDY DESIGN Analysis included 419 infants, greater than 35 weeks gestational age, with PCR(-), BC(-) and LOS > 48 h. Both the investigators and clinical care team were unaware of the PCR results. The actual number of antibiotic doses (AAD) administered was compared to an estimated number of antibiotics doses (EAD) that would have been given until PCR(-) results were available by 18 h. The number of antibiotic doses saved was calculated as (AAD-EAD). The actual NICU LOS in hours (aLOS) for a subset of infants who remained in the hospital primarily for antibiotic therapy was compared to an estimated LOS (eLOS) if infants with PCR(-) were discharged from the NICU when clinically stable. The number of hours saved was calculated as (aLOS-eLOS). RESULTS Approximately eight antibiotic doses and 85 NICU hours per infant could be saved using PCR(-) results available at 18 h. CONCLUSIONS Use of 16S rRNA PCR could decrease the number of antibiotics doses and NICU LOS for infants admitted for EOS. This may facilitate: (1) earlier NICU discharge; (2) parental satisfaction; and (3) decreased health care costs.
Collapse
Affiliation(s)
- B S Brozanski
- Department of Newborn Medicine, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
| | | | | | | |
Collapse
|
27
|
Quine D, Wong CM, Boyle EM, Jones JG, Stenson BJ. Non-invasive measurement of reduced ventilation:perfusion ratio and shunt in infants with bronchopulmonary dysplasia: a physiological definition of the disease. Arch Dis Child Fetal Neonatal Ed 2006; 91:F409-14. [PMID: 16798787 PMCID: PMC2672753 DOI: 10.1136/adc.2006.095406] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND An objective definition of bronchopulmonary dysplasia (BPD) is required to interpret trial outcomes and provide a baseline for prognostic studies. Current definitions do not quantify disease severity. The cardinal measures of impaired gas exchange are a reduced ventilation:perfusion ratio (V(A):Q) and increased right to left shunt. These can be determined non-invasively by plotting arterial oxygen saturation (Spo(2)) against inspired oxygen pressure (PIo(2)). AIMS To describe the reduced V(A):Q and shunt in infants with BPD and evaluate these as graded measures of pulmonary dysfunction. METHODS 21 preterm infants with BPD were studied. PIo(2) was changed stepwise to vary Spo(2) between 86% and 94%. Pairs of PIo(2) and Spo(2) data points for each infant were plotted and analysed to derive reduced V(A):Q ratio and shunt. RESULTS In every infant, the Spo(2) versus PIo(2) curve was shifted to the right of the normal because of a reduced V(A):Q. The mean (SD) shift was 16.5 (4.7) kPa (normal 6 kPa). Varying degrees of shunt were also present, but these were less important in determining Spo(2) within the studied range. The degree of shift was strongly predictive of the PIo(2) required to achieve any Spo(2) within the range 86-94% (R(2)>0.9), permitting shift and V(A):Q to be determined from a single pair of PIo(2) and SpO(2) values in this range. CONCLUSIONS The predominant gas exchange impairment in BPD is a reduced V(A):Q, described by the right shift of the Spo(2) versus PIo(2) relationship. This provides a simpler method for defining BPD, which can grade disease severity.
Collapse
Affiliation(s)
- D Quine
- Neonatal Unit, Royal Infirmary of Edinburgh, Edinburgh, UK
| | | | | | | | | |
Collapse
|
28
|
Jones JG, Carpenter RHS. Excessive daytime sleepiness and driving: regulations for road safety. Clin Med (Lond) 2004; 4:595; author reply 595-6. [PMID: 15656488 PMCID: PMC4952006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
|
29
|
Jones JG, Carpenter RHS, Lewis KE. Excessive daytime sleepiness and driving: regulations for road safety. Clin Med (Lond) 2004. [DOI: 10.7861/clinmedicine.4-6-595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
30
|
Abstract
Fixed performance venturi devices should provide a predetermined oxygen concentration at an outflow which exceeds an adult's peak resting inspiratory flow rate (approximately 30 l.min(-1)). Campbell's original description mentioned the sensitivity of the venturi device to downstream resistance but gave no further details. This study examined outflow and oxygen concentration from the five standard venturi devices (24-60% O(2)) when downstream pressure increased. Outflow was exquisitely sensitive to small increases in pressure. The outflow at zero downstream pressure for the 24-40% O(2) venturi devices ranged from 40 to 50 l.min(-1) but only 2-3 mmH(2)O was needed to halve this flow and increase oxygen concentration. The 60% O(2) venturi delivered a maximum of only 30 l.min(-1) at zero downstream pressure and flow was reduced further by increasing this pressure. An increase in downstream pressure of only a few mmH(2)O increased oxygen concentration and decreased outflow of all the venturi devices tested, in most to less than normal peak tidal flow in adults.
Collapse
Affiliation(s)
- J G Jones
- University Department of Anaesthesia, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK.
| |
Collapse
|
31
|
O'Hanlan KA, Levine PA, Harbatkin D, Feiner C, Goldberg GL, Jones JG, Rodriguez-Rodriguez L. Virulence of papillary endometrial carcinoma. Int J Gynaecol Obstet 2004. [DOI: 10.1016/0020-7292(90)90547-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Nouraei SAR, De Pennington N, Jones JG, Carpenter RHS. Dose-related effect of sevoflurane sedation on higher control of eye movements and decision making. Br J Anaesth 2003; 91:175-83. [PMID: 12878614 DOI: 10.1093/bja/aeg158] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Saccadic latency may provide an objective method to assess sedative doses of anaesthetic on cortical oculomotor mechanisms and decision making. METHODS We tested the effects of random doses of 0, 0.1, 0.2 and 0.3 MAC sevoflurane in six subjects, in a double-blind study using two measures of behavioural impairment: saccadic latency and stop signal reaction time (SSRT) in a countermanding task. RESULTS Saccadic latency and SSRT both increased with increasing doses of sevoflurane. In both measures, reciprocal reaction time was linearly related to dose in each subject: all but two of the twelve regression coefficients were statistically significant (P<0.05). In one subject, SSRT was significantly more sensitive than simple latency (P<0.05); for the others there was no significant difference. CONCLUSION Measurements of this kind could potentially provide estimates of cortical effects of sevoflurane sedation, and give a clinically useful measure of cognitive fitness.
Collapse
Affiliation(s)
- S A R Nouraei
- University Department of Anaesthesia, Level 4, Addenbrooke's Hospital, Cambridge UK
| | | | | | | |
Collapse
|
33
|
Abstract
Few cohort studies have examined the association between cigarette smoking and ovarian cancer risk, either overall, or by histological subtype. In relation to the latter, it has been suggested that mucinous ovarian tumours may be aetiologically unrelated to the other types of epithelial tumours and that their respective associations with cigarette smoking may differ. We examined the association between smoking and ovarian cancer risk using data from participants in a randomised controlled trial of screening for breast cancer involving 89,835 women aged 40-59 years at recruitment. Cox proportional hazards models were used to estimate rate ratios (RR) and 95% confidence intervals (CI). During an average of 16.5 years of follow-up, we observed 454 incident cases of ovarian cancer (184 serous, 67 endometrioid, 32 mucinous, 171 other or unknown). We found that women who had smoked for several decades had an approximately two-fold increased risk of epithelial ovarian cancer. Relative to never-smokers, women who had smoked for 40 years or more were at the highest risk (RR=2.50, 95% CI=1.37-4.56). The association with non-mucinous tumours was similar to that observed overall. For mucinous tumours, a two-fold increased risk was observed with smoking of shorter duration, although the number of mucinous tumours in our data-set was small. Long-term cigarette smoking may be associated with an increased risk of epithelial ovarian tumours.
Collapse
Affiliation(s)
- P D Terry
- Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Room 1301, Bronx, NY 10461, USA.
| | | | | | | |
Collapse
|
34
|
Jones JG, Jones SE. Discriminating between the effect of shunt and reduced VA/Q on arterial oxygen saturation is particularly useful in clinical practice. J Clin Monit Comput 2003; 16:337-50. [PMID: 12580217 DOI: 10.1023/a:1011495416005] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
There is an extensive literature on methods for discriminating between an increased shunt and a reduced ratio of ventilation to perfusion. In this review we prefer the terms "VA/Q" and "reduced or low VA/Q" rather than "V/Q inequality" to refer to the effects on arterial oxygenation of reducing V/Q below 0.8 to about 0.1. Almost without exception the conventional methods for measuring shunt and reduced VA/Q are invasive as well as technically complex. For most clinicians who are dealing with a hypoxemic patient the relevance of these entities is not so obvious as to justify the time and difficulty in either understanding or measuring them. However this review shows that, while an increased shunt and a decreased VA/Q both reduce arterial oxygen saturation (SaO2) at a particular inspired oxygen concentration (PIO2), the effect of shunt and reduced VA/Q have important clinical differences on the relationship between PIO2 and SaO2. The review also outlines a simple non-invasive method for measuring shunt and reduced VA/Q which illustrates the value of discriminating between them in clinical practice.
Collapse
Affiliation(s)
- J G Jones
- Department of Anaesthesia, Addenbrooke's Hospital, Cambridge, UK
| | | |
Collapse
|
35
|
Affiliation(s)
- J G Jones
- Woodlands, Rufforth, York YO2 3QF, UK.
| |
Collapse
|
36
|
Abstract
We investigated the effects of a low concentration of sevoflurane on a saccadic eye movement task that reflects the performance of higher neural decision and control mechanisms. The experiments were performed double-blind in five subjects, using either 0.15% end-tidal sevoflurane in oxygen, or pure oxygen as a placebo. Saccades were recorded and analysed using a computer-based recording system that also controlled the presentation of visual targets. Administration of oxygen produced no significant change in median latency compared with breathing air; but in four of the five subjects, administration of sevoflurane in oxygen caused a significant increase in latency. These results suggest that measurement of median saccadic latency may be a useful functional measurement of impairment of performance during recovery from anaesthesia.
Collapse
Affiliation(s)
- R H S Carpenter
- Reader in Oculomotor Physiology, Physiological Laboratory, Downing Street, Cambridge, CB2 3EG, UK.
| | | | | | | | | |
Collapse
|
37
|
Thorogood D, Kaiser WJ, Jones JG, Armstead I. Self-incompatibility in ryegrass 12. Genotyping and mapping the S and Z loci of Lolium perenne L. Heredity (Edinb) 2002; 88:385-90. [PMID: 11986876 DOI: 10.1038/sj.hdy.6800071] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2001] [Accepted: 01/15/2002] [Indexed: 11/09/2022] Open
Abstract
Perennial ryegrass (Lolium perenne L.) is an outcrossing, wind-pollinated species exhibiting a gametophytic two-locus system of self-incompatibility (S and Z). The two incompatibility loci were genotyped in a cross between a doubled-haploid plant crossed as the female parent with a normal heterozygous plant. The S and Z loci were found to segregate in the expected 1:1 ratio and also segregated independently. The two loci were mapped to linkage groups one and two respectively, in accordance with the Triticeae consensus map. In addition, there were notable associations between the segregation of particular alleles mapping to the S locus region of linkage group 1 and those mapping to the WG889/CDO920 loci region of linkage group 3 which resulted in significant segregation distortions. No such associations were found between the Z locus and this region or any other region of the genome. The L. perenne S and Z loci showed conserved synteny with the equivalent loci in rye (Secale cereale L.).
Collapse
Affiliation(s)
- D Thorogood
- Institute of Grassland and Environmental Research, Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, UK.
| | | | | | | |
Collapse
|
38
|
Byrne AJ, Sellen AJ, Jones JG, Aitkenhead AR, Hussain S, Gilder F, Smith HL, Ribes P. Effect of videotape feedback on anaesthetists' performance while managing simulated anaesthetic crises: a multicentre study. Anaesthesia 2002; 57:176-9. [PMID: 11871957 DOI: 10.1046/j.1365-2044.2002.02361.x] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The aim of this study was to examine the performance of anaesthetists while managing simulated anaesthetic crises and to see whether their performance was improved by reviewing their own performances recorded on videotape. Thirty-two subjects from four hospitals were allocated randomly to one of two groups, with each subject completing five simulations in a single session. Individuals in the first group completed five simulations with only a short discussion between each simulation. Those in the second group were allowed to review their own performance on videotape between each of the simulations. Performance was measured by both 'time to solve the problem' and mental workload, using anaesthetic chart error as a secondary task. Those trainees exposed to videotape feedback had a shorter median 'time to solve' and a smaller decrease in chart error when compared to those not exposed to video feedback. However, the differences were not statistically significant, confirming the difficulties encountered by other groups in designing valid tests of the performance of anaesthetists.
Collapse
Affiliation(s)
- A J Byrne
- Department of Anaesthesia, Morriston Hospital, Swansea SA6 6NL, UK
| | | | | | | | | | | | | | | |
Collapse
|
39
|
|
40
|
Jones JG. Airway obstruction and microsleep after surgery. Br J Anaesth 2001; 87:939; author reply 939-40. [PMID: 11878702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023] Open
|
41
|
Abstract
Hepatic glucose synthesis from glycogen, glycerol, and the tricarboxylic acid (TCA) cycle was measured in five overnight-fasted subjects by (1)H, (2)H, and (13)C NMR analysis of blood glucose, urinary acetaminophen glucuronide, and urinary phenylacetylglutamine after administration of [1,6-(13)C(2)]glucose, (2)H(2)O, and [U-(13)C(3)]propionate. This combination of tracers allows three separate elements of hepatic glucose production (GP) to be probed simultaneously in a single study: 1) endogenous GP, 2) the contribution of glycogen, phosphoenolpyruvate (PEP), and glycerol to GP, and 3) flux through PEP carboxykinase, pyruvate recycling, and the TCA cycle. Isotope-dilution measurements of [1,6-(13)C(2)] glucose by (1)H and (13)C NMR indicated that GP in 16-h-fasted humans was 10.7 +/- 0.9 micromol.kg(-1).min(-1). (2)H NMR spectra of monoacetone glucose (derived from plasma glucose) provided the relative (2)H enrichment at glucose H-2, H-5, and H-6S, which, in turn, reflects the contribution of glycogen, PEP, and glycerol to total GP (5.5 +/- 0.7, 4.8 +/- 1.0, and 0.4 +/- 0.3 micromol.kg(-1).min(-1), respectively). Interestingly, (13)C NMR isotopomer analysis of phenylacetylglutamine and acetaminophen glucuronide reported different values for PEP carboxykinase flux (68.8 +/- 9.8 vs. 37.5 +/- 7.9 micromol.kg(-1).min(-1)), PEP recycling flux (59.1 +/- 9.8 vs. 27.8 +/- 6.8 micromol.kg(-1).min(-1)), and TCA cycle flux (10.9 +/- 1.4 vs. 5.4 +/- 1.4 micromol.kg(-1).min(-1)). These differences may reflect zonation of propionate metabolism in the liver.
Collapse
Affiliation(s)
- J G Jones
- Department of Radiology, University of Texas Southwestern Medical Center, Dallas 75235, USA
| | | | | | | | | |
Collapse
|
42
|
Abstract
Before it is possible to predict the impact of human activities on the natural environment it is necessary to understand the forces that drive and, therefore, control that environment. This paper is concerned with the freshwater component of the aquatic environment. The driving forces involved (some of which are under man's control) can be divided into the physical and the chemical, but the response is, almost entirely, biological. Although most impacts of the food processing industry might be perceived to be on running waters, this is not always the case, but we can apply the same basic rules to both static and running waters. The physical forces that determine how a lake functions are as follows. In early spring, in the temperate zone, the temperature of the surface water in lakes rises and the sunlight input increases. This results in stratification of the water body. The cooler, deeper water is separated, physically, by gravity. This isolated water plays a very different role in the function of the lake and is analogous to how a river works. Man's activities drive these systems by our input of inorganic and organic substances. The inorganic inputs, particularly of phosphorous, stimulate undesirable algal growths, some of which may produce particularly dangerous toxins. We must now accept that climate change, driven by man, will exacerbate these problems. Organic inputs from the food industry, i.e., carbohydrates, lipids, and proteins, will all impact lakes and rivers by increasing the biological oxygen demand. The worst case scenario is total loss of oxygen from the water as a result of microbial activity. Lipids create the greatest oxygen demand but carbohydrates (more easily biodegradable) also result in unsightly "sewage fungus." Protein waste can be degraded to produce ammonia and sulfide, both of which produce toxicity problems. Bioremediation processes, particularly phytoremediation, can alleviate these problems in a cost-effective manner and this paper will address these options.
Collapse
Affiliation(s)
- J G Jones
- Freshwater Biological Association, The Ferry House, Ambleside, Cumbria LA22 0LP, United Kingdom
| |
Collapse
|
43
|
Abstract
Calretinin, a calcium-binding protein, is primarily expressed in certain subtypes of neurons. It has also been found to be present in mesothelial cells and mesotheliomas but not in many types of carcinomas. Using a polyclonal anti-calretinin antibody, we investigated the expression of calretinin immunohistochemically in nonneoplastic human ovaries and testes and ovarian sex cord-stromal tumors (SCSTs). In ovaries, calretinin was expressed in theca interna cells, hilus cells, and scattered individual stromal cells. Oocytes, granulosa cells, theca externa cells, rete ovarii, and most stromal cells were negative. Expression of calretinin was also seen in the ovarian surface epithelium and in collapsed and flat epithelial inclusion glands (EIGs), but not in round, columnar, and ciliated EIGs. In some glands, a transition from calretinin-positive to calretinin-negative epithelium was observed. In postpubertal testes, calretinin was expressed in Leydig cells, but not in germ cells or most rete testes and Sertoli cells. In ovarian SCSTs, strong calretinin staining was seen in all hilus cell tumors (4/4) and the Leydig cell component of Sertoli-Leydig cell tumors (10/10). The Sertoli cell component showed focal weak positivity in 5/10. Fibrothecomas were completely negative (0/8). In granulosa cell tumors, the tumor cells were either completely negative (8/14) or weakly positive at the periphery of the tumor (6/14) while scattered stromal cell staining was seen in 9/14 cases. The expression of calretinin in normal Leydig cells, theca interna cells, the Leydig cell component of Sertoli-Leydig cell tumors, and hilus cell tumors suggests its functional relationship with androgen production. Its pattern of expression in ovarian SCSTs is useful in the differential diagnosis of these tumors. The presence of a transition from calretinin-positive, flat, nonciliated epithelium to calretinin-negative, columnar, ciliated epithelium in the same glands provides strong evidence for mullerian metaplasia.
Collapse
Affiliation(s)
- Q J Cao
- Department of Pathology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA
| | | | | |
Collapse
|
44
|
Abstract
AIMS To make non-invasive measurements of right to left (R-L) shunt and reduced ventilation/perfusion ratio (V(A)/Q) in neonates with pulmonary failure and to examine sequential changes in these variables after treatment. METHODS Twelve neonates with pulmonary failure were studied. They ranged in gestational age from 24 to 37 (median 27) weeks and were 1-39 (median 4) days old. Shunt and reduced V(A)/Q were derived from their effects on the relation between inspired oxygen pressure (PIO(2)) and arterial oxygen saturation measured with a pulse oximeter (SpO(2)). Pairs of PIO(2) v. SpO(2) data points were obtained by varying PIO(2) in a stepwise fashion. A computer algorithm based on a model of pulmonary gas exchange fitted a curve to these data. With PIO(2) on the abscissa, an increase in shunt produced a downward movement of the curve, whereas reducing V(A)/Q to < 0.8 shifted the curve to the right. The right shift gives a variable that is inversely related to V(A)/Q, the PIO(2) - PO(2) difference, where PO(2) is mixed capillary oxygen pressure. RESULTS Ten of the 12 infants on the first study day had large shunts (range 5.9-31.0%, median 19.9%, normal < 8%) and large PIO(2) - PO(2) differences (range 9.7-64.4 kPa, median 19.8 kPa, normal < 7 kPa) equivalent to a median V(A)/Q of 0.2 (normal median V(A)/Q = 0.8). Sequential improvement in shunt and V(A)/Q were shown in most infants after treatment. Sudden large changes in these variables were shown in two infants. CONCLUSION This simple non-invasive method distinguishes between shunt and reduced V(A)/Q in neonates with pulmonary failure.
Collapse
Affiliation(s)
- H L Smith
- Cambridge University, Department of Anaesthesia, Addenbrooke's Hospital, Cambridge, UK
| | | |
Collapse
|
45
|
Abstract
BACKGROUND AND OBJECTIVE Variability in blink duration was examined to see whether it was sensitive to sevoflurane sedation at 0.05 and 0.1 minimum alveolar concentration (MAC). METHODS Blinks were measured with an infrared transducer in eight subjects. Sedation was scored using a visual analogue scale (VAS). RESULTS At baseline, 0.05 and 0.1 MAC sevoflurane, respectively, the overall median value of blink duration and its interquartile range were 95 (80-110) ms, 198 (163-245) ms and 210 (130-980) ms. The median percentage of blinks exceeding 500 ms was 0% (0-0.7%), 33.3% (25.5-34.7%) and 25% (15.7-63.3%) respectively. Values during 0.05 and 0.1 MAC sevoflurane were significantly different from baseline (P < 0.035) but not from each other. Baseline visual analogue scales showed large intersubject variability. Compared with baseline, VAS scores were higher at 0.05 MAC (P < 0.035) but not at 0.1 MAC. After discontinuing sevoflurane, median blink duration returned to baseline with a recovery half-life of 2.6 min (R2 = 0.95). Conclusion Blink duration is a sensitive measure of sevoflurane sedation even at 0.05 MAC.
Collapse
Affiliation(s)
- A K Jandziol
- University Department of Anaesthesia, Addenbrooke's Hospital, Cambridge, UK
| | | | | | | |
Collapse
|
46
|
Abstract
OBJECTIVE A review was made of the CT studies and pathology reports of four patients with surgically resected colonic villous adenomatous tumors, two of whom had focal carcinomatous invasion. CONCLUSION Two patients had villous tumors with IV contrast-enhancing convolutional gyral patterns. The other two patients had tumor masses that showed oral contrast medium collecting in surface interstices, analogous to findings with barium enemas. One of the latter also had an unusual cluster of mesenteric vessels adjacent to the lesion.
Collapse
Affiliation(s)
- T R Smith
- Department of Radiology, J. D. Weiler Hospital of the Albert Einstein College of Medicine and Montefiore Medical Center, 1825 Eastchester Rd., Bronx, NY 10461, USA
| | | | | |
Collapse
|
47
|
Pope KO, Pohl ME, Jones JG, Lentz DL, von Nagy C, Vega FJ, Quitmyer IR. Origin and environmental setting of ancient agriculture in the lowlands of Mesoamerica. Science 2001; 292:1370-3. [PMID: 11359011 DOI: 10.1126/science.292.5520.1370] [Citation(s) in RCA: 181] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
Archaeological research in the Gulf Coast of Tabasco reveals the earliest record of maize cultivation in Mexico. The first farmers settled along beach ridges and lagoons of the Grijalva River delta. Pollen from cultivated Zea appears with evidence of forest clearing about 5100 calendar years B.C. (yr B.C.) [6200 (14)C years before the present (yr B.P.)]. Large Zea sp. pollen, typical of domesticated maize (Zea mays), appears about 5000 calendar yr B.C. (6000 yr B.P.). A Manihot sp. pollen grain dated to 4600 calendar yr B.C. (5800 yr B.P.) may be from domesticated manioc. About 2500 calendar yr B.C. (4000 yr B.P.), domesticated sunflower seeds and cotton pollen appear as farming expanded.
Collapse
Affiliation(s)
- K O Pope
- Geo Eco Arc Research, 16305 St. Mary's Church Road, Aquasco, MD 20608, USA.
| | | | | | | | | | | | | |
Collapse
|
48
|
Jones JG. Is general practice losing its way? Patients' needs should be put first. BMJ 2001; 322:931. [PMID: 11334038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
|
49
|
Burgess SC, Carvalho RA, Merritt ME, Jones JG, Malloy CR, Sherry AD. 13C isotopomer analysis of glutamate by J-resolved heteronuclear single quantum coherence spectroscopy. Anal Biochem 2001; 289:187-95. [PMID: 11161312 DOI: 10.1006/abio.2000.4930] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
13C NMR isotopomer analysis is a powerful method for measuring metabolic fluxes through pathways intersecting in the tricarboxylic acid cycle. However, the inherent insensitivity of 13C NMR spectroscopy makes application of isotopomer analysis to small tissue samples (mouse tissue, human biopsies, or cells grown in tissue culture) problematic. (1)H NMR is intrinsically more sensitive than 13C NMR and can potentially supply the same information via indirect detection of 13C providing that isotopomer information can be preserved. We report here the use of J-resolved HSQC (J-HSQC) for 13C isotopomer analysis of tissue samples. We show that J-HSQC reports isotopomer multiplet patterns identical to those reported by direct 13C detection but with improved sensitivity.
Collapse
Affiliation(s)
- S C Burgess
- Department of Chemistry, University of Texas at Dallas, TX 75235, USA
| | | | | | | | | | | |
Collapse
|
50
|
Abstract
A simple and sensitive (2)H NMR measurement of (2)H(2)O enrichment from a 10 microl volume of body fluid is presented. The method allows (2)H-enrichment levels of 0.1% or above to be rapidly determined from 10 microl of plasma or urine. The measurement is insensitive to the presence of plasma protein, allowing direct analysis of (2)H(2)O enrichment from native plasma samples. Magn Reson Med 45:156-158, 2001.
Collapse
Affiliation(s)
- J G Jones
- Mary Nell and Ralph B. Rogers Magnetic Resonance Center, Department of Radiology, UT Southwestern Medical Center, Dallas, Texas 75235-9085, USA.
| | | | | |
Collapse
|